Sinclair P R, Bement W J, Haugen S A, Sinclair J F, Guzelian P S
V.A. Medical Center, White River Junction, Vermont 05001.
Cancer Res. 1990 Sep 1;50(17):5219-24.
Cytochromes P-450IIB1 and P-450IIB2 were recently shown to be inducible in rat hepatocyte cultures maintained on a reconstituted extracellular tumor matrix (Matrigel) as indicated by increases in P-450IIB1 and -IIB2 mRNAs and immunoreactive proteins (J. Cell. Physiol., 134: 309-323, 1988). Here we show that treatment of cultured rat hepatocytes with phenobarbital and other compounds known to induce P-450IIB1/2 in vivo increased spectral cytochrome P-450, immunoreactive proteins, and benzyloxy- and pentoxy-resorufin dealkylases, activities known to be specific for cytochrome P-450IIB1/2. These increases were observed when cells were cultured on either Matrigel or collagen matrix in Williams E medium. Cytochrome P-450III was also increased by phenobarbital and dexamethasone on either matrix. Propoxycoumarin depropylase activity, which has been proposed as a specific activity catalyzed by cytochrome P-450III, was increased 3-4-fold more by treatment with 3-methylcholanthrene than by phenobarbital or dexamethasone. The activity catalyzed by P-450III could be distinguished from that catalyzed by other P-450 forms using the specific inhibitor triacetyloleandomycin. Benzoyloxyresorufin dealkylase was also increased in these cells by treatment with 2,4,5,2',4',5'-hexachlorobiphenyl, glutethimide, or mephenytoin. Treatment with phenobarbital or 2-allyl-2-isopropylacetamide slightly induced 5-aminolevulinate synthase activity. 5-Aminolevulinate synthase activity was slightly increased in cells treated with phenobarbital or 2-allyl-2-isopropylacetamide. Succinyl acetone also induced 5-aminolevulinate synthase activity and, in combination with either of the other two drugs, synergistically increased the enzyme activity regardless of whether cells were cultured on collagen or Matrigel. These results indicate that with simple and economical enzyme assays for holocytochrome P-450 and 5-aminolevulinate synthase, the rat hepatocyte culture system can be used for studies of the interrelationships between phenobarbital induction of cytochrome P-450 and heme metabolism.
细胞色素P-450IIB1和P-450IIB2最近被证明在维持于重组细胞外肿瘤基质(基质胶)上的大鼠肝细胞培养物中是可诱导的,这表现为P-450IIB1和-IIB2信使核糖核酸及免疫反应性蛋白的增加(《细胞生理学杂志》,134: 309 - 323, 1988)。在此我们表明,用苯巴比妥及其他在体内已知可诱导P-450IIB1/2的化合物处理培养的大鼠肝细胞,可增加光谱细胞色素P-450、免疫反应性蛋白以及苄氧基和戊氧基试卤灵脱烷基酶,这些活性是细胞色素P-450IIB1/2所特有的。当细胞在Williams E培养基中的基质胶或胶原基质上培养时,观察到了这些增加。细胞色素P-450III在两种基质上也都被苯巴比妥和地塞米松增加。据认为是由细胞色素P-450III催化的丙氧基香豆素脱丙基酶活性,用3-甲基胆蒽处理后的增加幅度比用苯巴比妥或地塞米松处理后的高3 - 4倍。使用特异性抑制剂三乙酰竹桃霉素,可将P-450III催化的活性与其他细胞色素P-450形式催化的活性区分开来。用2,4,5,2',4',5'-六氯联苯、导眠能或美芬妥英处理这些细胞后,苄氧基试卤灵脱烷基酶也增加。用苯巴比妥或2-烯丙基-2-异丙基乙酰胺处理可轻微诱导5-氨基酮戊酸合酶活性。在用苯巴比妥或2-烯丙基-2-异丙基乙酰胺处理的细胞中,5-氨基酮戊酸合酶活性略有增加。琥珀酰丙酮也可诱导5-氨基酮戊酸合酶活性,并且与其他两种药物中的任何一种联合使用时,无论细胞是在胶原还是基质胶上培养,都会协同增加该酶的活性。这些结果表明,通过用于全细胞色素P-450和5-氨基酮戊酸合酶的简单且经济的酶测定,大鼠肝细胞培养系统可用于研究苯巴比妥诱导细胞色素P-450与血红素代谢之间的相互关系。